Global Brain PET-MRI Systems Market Size study & Forecast, by Phase (Clinical, Pre-Clinical), by Product (Traditional PET-MRI Systems, Helium-Free PET-MRI Systems), by End-Use (Hospitals, Diagnostic Imaging Centers, Others), and Regional Analysis, 2023-20

Global Brain PET-MRI Systems Market Size study & Forecast, by Phase (Clinical, Pre-Clinical), by Product (Traditional PET-MRI Systems, Helium-Free PET-MRI Systems), by End-Use (Hospitals, Diagnostic Imaging Centers, Others), and Regional Analysis, 2023-2030

Global Brain PET-MRI Systems Market is valued approximately at USD 326.3 Million in 2022 and is anticipated to grow with a growth rate of more than 5.1% over the forecast period 2023-2030. Brain PET-MRI systems are advanced medical imaging devices that combine the functional and molecular imaging capabilities of positron emission tomography (PET) with the detailed anatomical imaging provided by magnetic resonance imaging (MRI). These systems are specifically designed for capturing high-resolution images of the brain, offering comprehensive insights into its structure, function, and metabolic activity. The application of Brain PET-MRI systems is diverse and spans various fields, including neurology, psychiatry, and neuro-oncology. The utilization of Brain PET-MRI systems offers a holistic approach to brain imaging by combining functional, anatomical, and molecular information in a single scan. The driving factors that are boosting the market growth is advancement in imaging technology, rising prevalence of Neurological Disorders, growing importance of Precision Medicine.

According to the World Health Organization (WHO), up to one billion people globally are affected by a wide range of neurological disorders, including epilepsy, Alzheimer's disease, stroke, headaches, brain injuries, neuroinfections, multiple sclerosis, and Parkinson's disease. This increase in neurological disorders poses significant challenges and impacts individuals, families, and healthcare systems globally. The global precision medicine market is also contributing to the market growth. According to Statista, the global market for neurological disorders is projected to reach over 140 billion dollars by 2026. Moreover, integration of AI (Artificial Intelligence) and ML (Machine Learning) technologies is expected to create lucrative opportunities for the market growth. However, the high cost of PET-MRI Systems and limited availability to major healthcare institutions or research centers stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain PET-MRI Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share due to the growing prevalence of neurological disorders in the region, the American Neurological Association has reported that the most commonly observed neurological disorders in the United States include Alzheimer's disease, stroke, traumatic brain injury, epilepsy, multiple sclerosis, and Parkinson's disease. However, Asia Pacific is expected to be the fastest growing region during the forecast period, owing to a rise in the utilization of advanced diagnostic machines within research centers and universities, fueling the market growth. The increasing demand for diagnostic systems in countries such as India, Japan, and China is expected to be a key driver for the regional market in the coming years.

Major market player included in this report are:
Siemens Healthineers AG
Cubresa Inc.
Aspect Imaging Ltd.
Mediso Ltd.
Koninklijke Philips N.V.
Canon Medical Systems Corporation
Quality Electrodynamics
Shenzhen Mindray Bio-Medical Electronics Co.
GE Healthcare
MR Solutions

Recent Developments in the Market:
In January 2023, Canon Medical Systems USA Inc., a subsidiary of Canon Medical Systems Corporation, has successfully finalized a strategic partnership agreement with ScImage, Inc. This collaboration brings together Canon's expertise in cutting-edge diagnostic imaging technology and ScImage's capabilities, fostering advancements in the field of medical imaging.
In June 2023, Mindray has launched its BeneFusion i Series and u Series infusion systems, designed to provide enhanced precision, adaptive customization, and simplified operation, ensuring a high level of medication safety in diverse clinical settings. The new series will initially be available in specific countries and regions, offering healthcare professionals advanced infusion technology for improved patient care.
In April 2023, Siemens Healthineers expanded its manufacturing operations in India with the inauguration of an MRI facility in Bengaluru. This development is in line with the Government of India's PLI (Production-Linked Incentive) scheme. The facility's primary focus will be on manufacturing MAGNETOM Free.Star, a helium-free and user-friendly MRI system that offers high-quality imaging.

Global Brain PET-MRI Systems Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Phase, Product, End-Use, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Phase:
Clinical
Pre-Clinical

By Product:
Traditional PET-MRI Systems
Helium-Free PET-MRI Systems

By End-Use:
Hospitals
Diagnostic Imaging Centers
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Siemens Healthineers AG
Cubresa Inc.
Aspect Imaging Ltd.
Mediso Ltd.
Koninklijke Philips N.V.
Canon Medical Systems Corporation
Quality Electrodynamics
Shenzhen Mindray Bio-Medical Electronics Co.
GE Healthcare
MR Solutions

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.